Shots:

• Pfizer will utilize Flatiron’s de-identified- real-world datasets and analytical expertise to inform development strategies for clinical development projects across multiple tumor types and will jointly explore other ways to drive clinical development innovation with real-world data
• The collaboration focuses on integrating real-world data insights into clinical development across Pfizer’s oncology portfolio and will identify the future areas of collaboration which will evolve real-world evidence
• The collaboration includes datasets from multiple tumor types including NSCLC & CRC and will explore the implications of real-world data with the scientific and healthcare communities to utilize it in making a regulatory decision

Ref: Pfizer | Image: Stat

Click here to­ read full press release/ article